CNSide Diagnostics, a leader in precision diagnostics for central nervous system (CNS) cancers, is pleased to announce the addition of Kelly Kreitzburg Ondrasek, PhD, as Medical Science Liaison (MSL).

Dr. Kreitzburg Ondrasek brings extensive scientific expertise and a passion for translating complex clinical data into meaningful insights for healthcare providers. As part of the Medical Affairs team, she will serve as a key bridge between CNSide’s innovative diagnostics platform and the clinicians and researchers who use it to improve patient care in neuro-oncology.

In her role, Dr. Kreitzburg Ondrasek will focus on educating providers, supporting clinical adoption of the CNSide® Cerebrospinal Fluid (CSF) Assay Platform, and advancing the company’s mission to make precision diagnostics more accessible for patients with leptomeningeal metastases (LM) and other challenging CNS cancers.

“We’re excited to welcome Dr. Kreitzburg Ondrasek to CNSide,” said Russell Bradley, President & GM. “Her depth of scientific knowledge and clinical communication skills will be instrumental in helping providers understand and integrate our advanced diagnostics into patient care.”

Supporting CNSide’s Mission in Neuro-Oncology

At CNSide Diagnostics, our goal is to transform the care pathway for CNS cancers by providing highly sensitive cerebrospinal fluid (CSF) assays that support:

• Early and accurate cancer detection within the central nervous system
• Real-time monitoring of disease progression and treatment response
• Informed, data-driven therapeutic decisions to personalize care for patients with LM and other CNS cancers

Adding top talent like Dr. Kreitzburg Ondrasek strengthens CNSide’s ability to engage with physicians, share scientific insights, and drive adoption of precision diagnostics that improve outcomes for patients.

Learn More About Our Team & Mission

Meet the CNSide Team and Explore Our Mission: CNSide Mission & Values
About CNSide® Diagnostics: CNSide Official Website

#CNSide #Diagnostics #Biotech #HealthcareInnovation #Oncology #CancerDiagnostics #PrecisionMedicine #LifeSciences #Biotechnology #Healthcare #NewHire